| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Mona Nasser | Q28037217 |
| Saman Warnakulasuriya | Q43975871 | ||
| Alan J. Mighell | Q47828989 | ||
| Thomas Dietrich | Q51525852 | ||
| P2093 | author name string | N W Johnson | |
| A Jalil | |||
| S Silverman | |||
| P A Reichart | |||
| T Nagao | |||
| F Fortune | |||
| A J Mighell | |||
| M M Bornstein | |||
| A R Kerr | |||
| J Rimal | |||
| V H Hazarey | |||
| P2860 | cites work | Adhesively bonded versus non-bonded amalgam restorations for dental caries | Q24240540 |
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials | Q29619671 | ||
| Role of KTP-532 laser in management of oral submucous fibrosis | Q33374881 | ||
| Interferon gamma (IFN-gamma) may reverse oral submucous fibrosis | Q33930209 | ||
| Curcumin as a therapeutic agent: the evidence from in vitro, animal and human studies. | Q34094663 | ||
| Oral submucous fibrosis--treatment with hyalase | Q34197253 | ||
| Oral submucous fibrosis: a new concept in surgical management. Report of 100 cases | Q34380545 | ||
| Use of diode laser in oral submucous fibrosis with trismus: prospective clinical study | Q34465682 | ||
| Global epidemiology of areca nut usage | Q34568461 | ||
| Efficacy of lycopene in the management of oral submucous fibrosis | Q34603631 | ||
| Curcumin in Cancer Chemoprevention: Molecular Targets, Pharmacokinetics, Bioavailability, and Clinical Trials | Q34622690 | ||
| How to formulate research recommendations | Q35082894 | ||
| Safety and anti-inflammatory activity of curcumin: a component of tumeric (Curcuma longa). | Q35098971 | ||
| Smokeless tobacco and health in India and South Asia | Q35621606 | ||
| Molecular pathogenesis of oral submucous fibrosis--a collagen metabolic disorder | Q36157193 | ||
| Oral submucous fibrosis: review on aetiology and pathogenesis | Q36323909 | ||
| Anti-angiogenic cancer therapy based on integrin alphavbeta3 antagonism | Q36611736 | ||
| Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases | Q36788410 | ||
| Nomenclature and classification of potentially malignant disorders of the oral mucosa | Q36974891 | ||
| Drug treatment of oral submucous fibrosis: a review of the literature | Q37521287 | ||
| A critical review of visual analogue scales in the measurement of clinical phenomena | Q37942859 | ||
| Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress. | Q43001517 | ||
| Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. | Q43808765 | ||
| Areca nut-abuse liability, dependence and public health | Q43921429 | ||
| Health professional perspective on disability in head and neck cancer. | Q53172511 | ||
| Malignant transformation rate in oral submucous fibrosis over a 17-year period. | Q53541061 | ||
| Oral submucous fibrosis--a new treatment regimen. | Q54375756 | ||
| Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. | Q54711596 | ||
| P921 | main subject | systematic review | Q1504425 |
| oral submucous fibrosis | Q7099404 | ||
| P304 | page(s) | 42-57 | |
| P577 | publication date | 2011-04-01 | |
| P1433 | published in | Oral Diseases | Q15724675 |
| P1476 | title | A systematic review of medical interventions for oral submucous fibrosis and future research opportunities | |
| P478 | volume | 17 Suppl 1 |
| Q38324762 | A Cyclin-Dependent Kinase Inhibitor, Dinaciclib, Impairs Homologous Recombination and Sensitizes Multiple Myeloma Cells to PARP Inhibition |
| Q50916892 | Areca nut chewing in an expatriate population in Sydney: report of two cases. |
| Q97885590 | Clinical efficacy of mouth exercising devices in oral submucous fibrosis: A systematic review |
| Q39229595 | Current protocols in the management of oral submucous fibrosis: An update |
| Q39154897 | Effectiveness of Osteopathic Therapy in the Treatment of Oral Submucous Fibrosis |
| Q99239104 | Efficacy of betamethasone, hyaluronidase and its combination on mouth opening, burning sensation and QOL in patients with OSF |
| Q38938921 | Efficacy of curcumin in the treatment for oral submucous fibrosis - A randomized clinical trial |
| Q41028176 | Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis |
| Q38389355 | Estimation of serum and salivary immunoglobulin G and immunoglobulin A in oral pre-cancer: A study in oral submucous fibrosis and oral lichen planus |
| Q53526526 | Estimation of serum malondialdehyde and assessment of DNA damage using comet assay in patients with oral submucous fibrosis. |
| Q34809789 | Eustachian tube dysfunction in OSMF- often present seldom discovered |
| Q96137546 | Expression of transforming growth factor beta in oral submucous fibrosis |
| Q50328261 | Grading the quality of evidence and strength of recommendations: the GRADE approach to improving dental Clinical Guidelines. |
| Q91897056 | Habit History in Oral Submucous Fibrosis: Have We Over Emphasized? |
| Q38176431 | Management for premalignant lesions of the oral cavity |
| Q38190109 | Management for premalignant lesions of the oral cavity. |
| Q41895151 | Management of oral submucous fibrosis by different surgical approaches: report of three cases |
| Q99558071 | Medicinal management of oral submucous fibrosis in the past decade- A systematic review |
| Q38081511 | Oral cancer in India continues in epidemic proportions: evidence base and policy initiatives. |
| Q92501754 | Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management |
| Q37391789 | Oral submucous fibrosis: a premalignant condition in a 14-year-old Indian girl. |
| Q91714008 | Potentially malignant disorders of the oral cavity and oral dysplasia: A systematic review and meta-analysis of malignant transformation rate by subtype |
| Q38183795 | Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory |
| Q33565546 | Qualitative analysis of the impact of Oral Potentially Malignant Disorders on daily life activities |
| Q38213101 | Report on World Workshops on Oral Medicine (WWOM) IV and V: research themes and citation impact: WWOM VI steering committee |
| Q91897016 | Risk Assessment of Smokeless Tobacco among Oral Precancer and Cancer Patients in Eastern Developmental Region of Nepal |
| Q37903902 | Squamous cell carcinoma and precursor lesions: prevention |
| Q35994219 | The use of buccal fat pad in the treatment of oral submucous fibrosis: a newer method |
| Q35650172 | Treatment of oral submucous fibrosis using split skin graft and a polyethylene stent: a prospective study |
| Q41880725 | Ultrasonographic evaluation of oral submucous fibrosis in habitual areca nut chewers. |
| Q89284152 | Validity of Chronic Oral Mucosal Diseases Questionnaire in oral submucous fibrosis |
| Q36730393 | Various forms of tobacco usage and its associated oral mucosal lesions |
| Q39243513 | Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis |
Search more.